Events

Retiro De Equipo (Recall) de Electrodes for disposable foot-operated electrosurgical instruments

Según Korean Food & Drug Administration, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en South Korea que fue producido por Medtronic Korea.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
    Recall
  • ID del evento
    369
  • Fecha
    2015-09-25
  • País del evento
    South Korea
  • Fuente del evento
    KFDA
  • URL de la fuente del evento
    https://emed.mfds.go.kr
  • Notas / Alertas
    Korean data is current through September 2018. All of the data comes from Korean Food & Drug Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and South Korea.
  • Notas adicionales en la data
    Su-in 13-3597

Device

Electrodes for disposable foot-operated electrosurgical instruments

Manufacturer

Medtronic Korea
  • Dirección del fabricante
    Seoul, Korea 534 Teheran-ro, Gangnam-gu, Seoul
  • Empresa matriz del fabricante (2017)
    Medtronic plc
  • Comentario del fabricante
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    KFDA